Excitatory amino-acid transporters (EAATs) are structurally related plasma membrane proteins that mediate the high-affinity uptake of the acidic amino acids glutamate and aspartate released at excitatory synapses, and maintain the extracellular concentrations of these neurotransmitters below excitotoxic levels [1-4]. Several members of the EAAT family have been described previously. So far, all known EAATs have been reported to transport glutamate and aspartate with a similar affinity. Here, we report that dEAAT2 -a nervous tissue-specific EAAT homologue that we recently identified in the fruit fly Drosophila [5] -is a selective Na + -dependent high-affinity aspartate transporter (K m = 30 µ µM). We found that dEAAT2 can also transport L-glutamate but with a much lower affinity (K m = 185 µ µM) and a 10-to 15-fold lower relative efficacy (V max /K m ). Competition experiments showed that the binding of glutamate to this transporter is much weaker than the binding of D-or L-aspartate. As dEAAT2 is the first known EAAT to show this substrate selectivity, it suggests that aspartate may play a specific role in the Drosophila nervous system. 
Results and discussion
The acidic amino acid L-glutamate has long been known to be involved in excitatory neurotransmission in arthropods [6] and Drosophila [7] . We previously isolated two Drosophila EAATs, dEAAT1 (also identified by Seal et al. [8] ) and dEAAT2, which show 35-45% amino-acid identity with vertebrate EAAT sequences and have a similar hydrophobic profile [5] . Although dEAAT1 and dEAAT2 are both specifically expressed in the nervous system, they have different patterns of cellular expression [5] . The pattern of expression of dEAAT1 and dEAAT2 in the Drosophila embryonic central nervous system (CNS) is shown in Figure 1 ; dEAAT1 is expressed in several rows of cells, whereas a smaller number of apparently distinct cells (4-6 per hemisegment) express dEAAT2 in the nerve cord.
All known vertebrate EAAT proteins transport L-glutamate and D-or L-aspartate with high affinity, and this active transport is driven by the Na + /K + electrochemical gradient. Likewise, in insects, Drosophila dEAAT1 and the closely related (59% amino-acid identity) TrnEAAT1 from the caterpillar Trichoplusia ni have been found to transport both glutamate and aspartate with high affinity [8, 9] . The Drosophila EAATs, dEAAT1 and dEAAT2, are distantly related and show only 36% identity at the amino-acid level. To characterise the transport properties of dEAAT2, we transiently transfected the dEAAT1 and dEAAT2 cDNAs into Drosophila Schneider S2 cells. S2 cells do not endogenously express either dEAAT1 or dEAAT2, as assayed by reverse transcription PCR (data not shown). In addition, a significant uptake of D-aspartate in untransfected S2 cells was detected only at millimolar substrate concentration, which shows that these cells do not have an endogenous high-affinity transport system for excitatory amino acids. Figure 1a (right panel) shows that, at a substrate concentration of 1 µM, the uptake of either L-glutamate or the non-metabolisable substrate analogue D-aspartate is significantly enhanced in S2 cells transiently transfected with the dEAAT1 cDNA. This result confirms the data obtained in COS-7 cells with dEAAT1 [8] and shows that S2 cells are suitable for studying excitatory amino acid transport. By contrast, although D-aspartate transport was enhanced in a similar way in S2 cells transfected with the dEAAT2 cDNA, these cells did not show any significant transport of L-glutamate at 1 µM as compared with the untransfected cells (Figure 1b, right panel) . These results show that the two Drosophila EAATs differ strikingly in their substrate discrimination.
To further characterise the transport mediated by dEAAT2, we isolated a polyclonal S2 cell line that stably expresses dEAAT2. Uptake experiments with these cells confirmed the results of the transient expression studies. At a substrate concentration of 1 µM, the dEAAT2-expressing cells transported L-aspartate and D-aspartate; transport of L-glutamate was not significant (Figure 2a ). Uptake by dEAAT2 was found to be linear with time up to 10 minutes at 1 µM D-aspartate and up to 2 minutes at 1 mM D-aspartate (data not shown). The kinetic parameters were therefore determined after 2 minutes of uptake. We observed that dEAAT2 can transport L-glutamate but less efficiently and with a much lower affinity (Figure 2b) (Figure 2b and Table 1 ), indicating a high affinity, whereas the K m value obtained with L-glutamate was much higher, around 185 µM. As the V max is also higher with aspartate than with L-glutamate, the relative efficacy (V max /K m ) of the uptake of L-glutamate appears 10-15-fold lower than that of L-or D-aspartate, respectively, with dEAAT2 (Table 1 ). For the sake of comparison, the K m values previously published in the case of the human transporters hEAAT1 and hEAAT2 were 60 µM and 54 µM, respectively, with aspartate and 45 and 66 µM with L-glutamate [3] .
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33.7 ± 6.2 149.7 ± 21. 
Figure 2
Substrate discrimination of dEAAT2-mediated transport. Figure 3b shows that only a large excess of L-glutamate (1 mM) was able to compete significantly. So L-glutamate is apparently much less efficient than L-aspartate in inhibiting the uptake of 1 µM D-aspartate by dEAAT2. These results suggest that a low binding affinity for glutamate is at least partly responsible for the low efficiency of dEAAT2 in transporting L-glutamate. We also observed that neither L-proline, glycine nor L-cysteine, a neutral amino acid that is a specific substrate for hEAAT3 [10] , at a concentration of 100 µM, competed with 1 µM D-aspartate for uptake by dEAAT2 (data not shown). Therefore, dEAAT2 is a high-affinity aspartate transporter that exhibits a stricter substrate selectivity than all the other known EAATs. This protein could be the first member of a new subfamily of EAATs that discriminates between the aspartate and glutamate substrates.
Other properties of D-aspartate transport by dEAAT2 are presented in Figure 4 . The uptake depends on the presence of Na + ions in the extracellular medium, as is generally true of EAATs (Figure 4a ). Three specific competitive inhibitors of vertebrate EAATs, namely L-trans-pyrrolidine-2,4-dicarboxylic acid (PDC), L(-)-threo-3-hydroxyaspartic acid (THA) and L-dihydrokainic acid (DHK), were tested to determine their ability to reduce D-aspartate transport by dEAAT2. All three compounds were found to compete efficiently with the dEAAT2-mediated uptake of D-aspartate ( Figure 4b ). It can be noted that two Ser residues, which are characteristic of the GLT1/EAAT2 subtypes of transporters (Ser440 and Ser443 in rat GLT1) and are involved in the binding of DHK [11] , are conserved at equivalent positions in dEAAT2.
Pines et al. [12] have reported that the mutagenesis of a conserved glutamate residue (Glu404) in rat GLT1 selectively impaired L-glutamate transport, the efficiency of which decreased to about 10% in comparison with the wild-type transporter, but not D-or L-aspartate transport. This acidic residue, which is always present at equivalent positions in other EAAT sequences, is replaced by a neutral residue, an isoleucine (Ile392), in dEAAT2, which suggests a possible structural basis for the substrate selectivity of dEAAT2. Importantly, however, glutamate binding to GLT1 was not impaired by the mutagenesis of Glu404 [12] , whereas glutamate binding to dEAAT2 is very low in comparison with
Brief Communication 209 aspartate binding (Figure 3 ). Other structural differences must obviously be responsible for the substrate discrimination of dEAAT2. In addition, mutation of Glu404 in rat GLT1 abolished the interaction with K + ions and converted the transporter into an amino-acid exchanger [13] , which suggests that dEAAT2 may be an exchanger that does not interact with K + . However, another residue, His326, which has been found to be necessary for the transport activity of rat GLT1 [14] , is not conserved in dEAAT2. So it may not be reliable to assign any functional significance to a particular residue by making comparisons with data obtained on a distantly related transporter. Further experiments are needed to analyse the transport mechanism of dEAAT2 and the associated ionic fluxes.
Finally, what might the physiological function of a selective high-affinity aspartate transporter be in the nervous system? The authors of a recent report demonstrated that aspartate can be concentrated in synaptic vesicles in vertebrate hippocampal excitatory nerve terminals and released by exocytosis [15] . As dEAAT2 is expressed in only a few subsets of cells in the Drosophila embryonic nerve cord and the peripheral nervous system, it seems unlikely that it plays a trophic role. It is tempting to speculate that L-aspartate may be used in some neurones as a neural signalling molecule and that dEAAT2 may be involved in concert with dEAAT1 in transmitter recycling. Further work is required to determine whether L-aspartate and dEAAT2 are involved in synaptic function in the Drosophila CNS and to what extent a selective high-affinity aspartate transport process has been conserved in the nervous system throughout the course of evolution.
Materials and methods

Construction of the dEAAT expression vectors
The dEAAT1 and dEAAT2 cDNA fragments containing the entire open reading frame were subcloned into the expression vector pPacPL, downstream of the constitutive actin 5C promoter, by inserting a 2.7 kb BamHI-NotI fragment of the dEAAT1 cDNA into the polylinker sites of the pPacPL vector, and a 2.2 kb SspI fragment of the dEAAT2 cDNA into the vector EcoRV site.
S2 cell transfection
The Drosophila Schneider S2 cell line was maintained at 25°C in Shields and Sang M3 medium (Sigma) supplemented with 10% heatinactivated foetal calf serum (Gibco-BRL), 100 units/ml penicillin and 100 µg/ml streptomycin. Cells were subcultured at 25°C on 100 mm plates in 5 ml medium. Transient transfection was carried out by performing calcium phosphate precipitation with 5 µg dEAAT expression vector or control plasmid; 24 h after the transfection, the DNA precipitate was discarded. Stable transfection was obtained in a similar way by cotransfecting 5 µg dEAAT expression vector with 1 µg pMK33 plasmid carrying a hygromycin B resistance gene. Hygromycin B (400 µg/ml) selection was performed to establish a stably transformed polyclonal cell line, which was isolated after about 10 weeks and maintained in the presence of hygromycin.
Transport assay
A few hours before the assay, the transfected cells were harvested and subcultured at a density of about 2 × 10 6 per ml in 6-well culture plates (Falcon). The cells were washed three times in 2 ml saline solution , plus 1 µM of the corresponding unlabelled substrate. After a 2 min incubation at 25°C, the uptake was stopped by three 3 ml washes with an ice-cold Na + -free saline solution. The cells were air dried and finally disrupted in 500 µl 1 N NaOH. Aliquots were used for radioactivity measurements and protein determination with the Lowry method. Amino-acid transport was expressed in pmol per min per mg protein. All uptake data are the mean ± S.E. of triplicate determinations. Kinetic data were analysed using the least square curve fitting method with the MacCurveFit program (Kevin Raner). Whole mount in situ hybridization and RT-PCR were performed as previously described [5] .
